000 | 02191 a2200625 4500 | ||
---|---|---|---|
005 | 20250516084744.0 | ||
264 | 0 | _c20121212 | |
008 | 201212s 0 0 eng d | ||
022 | _a1423-0216 | ||
024 | 7 |
_a10.1159/000336981 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCosentino, Marco | |
245 | 0 | 0 |
_aDopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy. _h[electronic resource] |
260 |
_bNeuroimmunomodulation _c2012 |
||
300 |
_a283-92 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aCD4 Antigens _xmetabolism |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aDisability Evaluation |
650 | 0 | 4 |
_aDopamine _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aForkhead Transcription Factors _xgenetics |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
650 | 0 | 4 |
_aInterleukin-2 Receptor alpha Subunit _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
650 | 0 | 4 | _aPhytohemagglutinins |
650 | 0 | 4 | _aRNA, Messenger |
650 | 0 | 4 |
_aReceptors, Dopamine D3 _xgenetics |
650 | 0 | 4 |
_aReceptors, Dopamine D5 _xgenetics |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _xdrug effects |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xgenetics |
700 | 1 | _aZaffaroni, Mauro | |
700 | 1 | _aTrojano, Maria | |
700 | 1 | _aGiorelli, Maurizio | |
700 | 1 | _aPica, Carmela | |
700 | 1 | _aRasini, Emanuela | |
700 | 1 | _aBombelli, Raffaella | |
700 | 1 | _aFerrari, Marco | |
700 | 1 | _aGhezzi, Angelo | |
700 | 1 | _aComi, Giancarlo | |
700 | 1 | _aLivrea, Paolo | |
700 | 1 | _aLecchini, Sergio | |
700 | 1 | _aMarino, Franca | |
773 | 0 |
_tNeuroimmunomodulation _gvol. 19 _gno. 5 _gp. 283-92 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000336981 _zAvailable from publisher's website |
999 |
_c21675238 _d21675238 |